Due to the widespread nature of the infection, the doctor was unable to treat dacryocystorhinostomy and dacryptocystoplasty. The patient is a 27-year-old man who was treated with antibiotics for two months due to severe infection, swelling and redness, and severe pain in the lacrimal and tear duct. The purpose of this report is to present the clinical experience of Iranian Traditional Medicine that has the highest therapeutic effect in the shortest time. Treatment success was found to be related to both the type of CNLDO and age.Ībs tract Treatment methods for infection and obstruction of the lacrimal duct and selection of therapeutic methods for its elimination are usually controversial. Primary BCI using nasal endoscopic visualisation has a favourably high success rate for treating CNLDO in children aged 4 to 13 years. Surgical success was 100% in the membranous type of CNLDO and 61.9% in the complex CNLDO group.Conclusions The median age of patients with a membranous and complex type of CNLDO were 60 months and 96 months, respectively. Membranous type of CNLDO was observed in 47.5% (19/40) of the cases. The success rate was lower in older children. A statistically significant correlation was observed between the age and success rate (p = 0.006). Treatment success was achieved in 32 of 40 eyes (80.0%). Therapeutic success was defined as the normal result of the fluorescein dye disappearance test and complete resolution of previous lacrimal symptoms and signs.ResultsThe median age was 80 (range 48–156) months. The children were followed up for 6 months after the removal of tubes. The mean silicone tube removal time was 4.3 ± 0.9 months (ranging from 3 to 6 months). The type of CNLDO was determined by endonasal endoscopic visualisation. MethodsA total of 40 eyes from 33 children (18 males, 15 females) with CNLDO who underwent bicanalicular intubation were evaluated. PurposeTo evaluate the clinical outcomes of endoscopic guided primary bicanalicular intubation (BCI) for congenital nasolacrimal duct obstruction (CNLDO) in children older than 4 years. Treatment success was reported in 65 of 84 eyes (77% 95% confidence interval, 65%-85%) in the balloon catheter dilation group compared with 72 of 88 eyes (84% after adjustment for intereye correlation 74%-91%) in the nasolacrimal intubation group (risk ratio for success for intubation vs balloon dilation, 1.08 0.95-1.22).īoth balloon catheter dilation and nasolacrimal duct intubation alleviate the clinical signs of persistent nasolacrimal duct obstruction in a similar percentage of patients. Treatment success was defined as absence of epiphora, mucous discharge, or increased tear lake at the outcome visit 6 months after surgery. One hundred ninety-nine eyes underwent either balloon catheter nasolacrimal duct dilation or nasolacrimal duct intubation. We conducted a prospective, nonrandomized, multicenter study that enrolled 159 children aged 6 months to younger than 48 months who had a history of a single failed nasolacrimal duct probing and at least 1 of the following clinical signs of nasolacrimal duct obstruction: epiphora, mucous discharge, or increased tear lake. To compare the outcomes of balloon catheter dilation and nasolacrimal intubation as treatment for congenital nasolacrimal duct obstruction after failed probing in children younger than 4 years.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |